HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rimonabant ameliorates insulin resistance via both adiponectin-dependent and adiponectin-independent pathways.

Abstract
Rimonabant has been shown to not only decrease the food intake and body weight but also to increase serum adiponectin levels. This increase of the serum adiponectin levels has been hypothesized to be related to the rimonabant-induced amelioration of insulin resistance linked to obesity, although experimental evidence to support this hypothesis is lacking. To test this hypothesis experimentally, we generated adiponectin knock-out (adipo(-/-))ob/ob mice. After 21 days of 30 mg/kg rimonabant, the body weight and food intake decreased to similar degrees in the ob/ob and adipo(-/-)ob/ob mice. Significant improvement of insulin resistance was observed in the ob/ob mice following rimonabant treatment, associated with significant up-regulation of the plasma adiponectin levels, in particular, of high molecular weight adiponectin. Amelioration of insulin resistance in the ob/ob mice was attributed to the decrease of glucose production and activation of AMP-activated protein kinase (AMPK) in the liver induced by rimonabant but not to increased glucose uptake by the skeletal muscle. Interestingly, the rimonabant-treated adipo(-/-)ob/ob mice also exhibited significant amelioration of insulin resistance, although the degree of improvement was significantly lower as compared with that in the ob/ob mice. The effects of rimonabant on the liver metabolism, namely decrease of glucose production and activation of AMPK, were also less pronounced in the adipo(-/-)ob/ob mice. Thus, it was concluded that rimonabant ameliorates insulin resistance via both adiponectin-dependent and adiponectin-independent pathways.
AuthorsTaku Watanabe, Naoto Kubota, Mitsuru Ohsugi, Tetsuya Kubota, Iseki Takamoto, Masato Iwabu, Motoharu Awazawa, Hisayuki Katsuyama, Chiaki Hasegawa, Kumpei Tokuyama, Masao Moroi, Kaoru Sugi, Toshimasa Yamauchi, Tetsuo Noda, Ryozo Nagai, Yasuo Terauchi, Kazuyuki Tobe, Kohjiro Ueki, Takashi Kadowaki
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 284 Issue 3 Pg. 1803-12 (Jan 16 2009) ISSN: 0021-9258 [Print] United States
PMID19008231 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adiponectin
  • Adipoq protein, mouse
  • Piperidines
  • Pyrazoles
  • AMP-Activated Protein Kinases
  • Glucose
  • Rimonabant
Topics
  • AMP-Activated Protein Kinases (metabolism)
  • Adiponectin (blood, genetics)
  • Animals
  • Body Weight (drug effects)
  • Eating (drug effects)
  • Glucose (metabolism)
  • Insulin Resistance (genetics)
  • Liver (metabolism)
  • Mice
  • Mice, Knockout
  • Mice, Obese
  • Muscle, Skeletal (metabolism)
  • Piperidines (pharmacology)
  • Pyrazoles (pharmacology)
  • Rimonabant

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: